Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts Boston University, Boston, Massachusetts